On this site WHO is gathering the latest scientific findings and knowledge on coronavirus disease (COVID-19) and compiling it in a database. They are updating the database daily from searches of bibliographic databases, hand searches of the table of contents of relevant journals, and the addition of... other relevant scientific articles that come to our attention. The entries in the database may not be exhaustive and new research will be added regularly.
more
Free access to COVID-19 publications by some publishers namely Elsevier, JAMA, NEJM , CDC, Lancet, Cell, BMJ, Oxford, Nature, Wiley, Cambridge, medRvix
Cochrane provides high-quality, relevant, and up-to-date synthesized research evidence to inform health decisions. This page highlights content relating to the coronavirus (COVID-19) pandemic and the various related activities that Cochrane is undertaking in response.
They will be continually add...ing updates and additions to this page. Sections include information and resources for:
Public, patients, and carers
Healthcare workers
Researchers
Policy and guideline developers
The Cochrane Community
more
Older people are at higher risk for more serious complications from COVID-19. COVID-19 is a new disease and we are learning more about it every day.
Evidencias COVID-19 es un recurso que ofrece información relevante relacionada con la pandemia del coronavirus SARS-CoV-2 y la COVID-19.
Este recurso recoge una serie de documentos que sintetizan la información más relevante para dar respuesta a preguntas clínicas y temas prioritarios sobre l...a pandemia, en forma de revisiones de la literatura y evaluaciones críticas de estudios. Los documentos han sido elaborados por integrantes de la Red Cochrane Iberoamericana con la intención de sintetizar y actualizar el conocimiento disponible en relación con la COVID-19 y son compartidos con la intención de dar una respuesta colaborativa a la situación actual.
more
Links to to summarised versions of Cochrane Reviews from EPOC and other groups that may be of particular relevance in pandemic situations such as COVID-19:
To help health- and social-system leaders as they respond to unprecedented challenges related to the COVID-19 pandemic, teams from the McMaster Health Forum and Ottawa Hospital Research Institute – as part of their contribution to RISE – and the Africa Centre for Evidence have compiled a list of... evidence sources.
more
This tracker, developed by the Vaccine Centre at the London School of Hygiene & Tropical Medicine, will follow COVID-19 vaccine candidates as they progress through the development pipeline. We will update it weekly. An overview of the different vaccine types as well as the phases of clinical develo...pment is provided in the Summary tab.
more
A growing number of studies and reports are being published on COVID-19 and the pandemic. This project will help decision makers and researchers navigate the research.
It provides an overview of scientific publications on COVID-19 categorized and parsed into more specific subgroups, providing quick... access to specific topic-relevant publications. As a result, the map also identifies research gaps, possibly guiding further research efforts.
They conduct literature searches daily or every other day in PubMed
more
Le CNRS se mobilise pour vous donner des informations scientifiques fiables sur la pandémie du coronavirus COVID-19
Das Kompetenznetz Public Health zu COVID-19 ist ein Ad hoc-Zusammenschluss von über 25 wissenschaftlichen Fachgesellschaften aus dem Bereich Public Health, die hier ihre, methodische, epidemiologische, statistische, sozialwissenschaftliche und (bevölkerungs-)medizinische Fachkenntnis bündeln. Gem...einsam vertreten wir mehrere Tausend Wissenschaftler*innen aus Deutschland, Österreich und der Schweiz.
more
FIND conducted independent evaluations at the University Hospitals of Geneva (HUG), to verify the limit of detection (LOD) and the clinical performance (as reported by the manufacturers) of the following molecular test kits. The LOD analysis was performed using cultured viral stocks from a clinical ...isolate from Switzerland, and quantified using an E gene standard. The clinical performance analysis was conducted on extracted samples from individuals suspected to have COVID-19 that were tested using an in-house PCR protocol that was optimized based on the Tib Molbiol assay.
more
Tests zur Detektion einer Infektion mit SARS-CoV-2 (neuartiges Coronavirus) sowie zum Nachweis von Antikörpern gehören zu den sog. In-vitro-Diagnostika (IVD). Das erstmalige Inverkehrbringen von In-vitro-Diagnostika auf dem deutschen Markt ist nach §§ 25 und 30 Medizinproduktegesetz (MPG) anzeig...epflichtig. Das DIMDI betreibt dafür die Datenbank "In-vitro-Diagnostika-Anzeigen (MPIVDA)", in welcher demnach auch Daten von "Corona-Tests" von den anzeigepflichtigen deutschen Herstellern und Bevollmächtigten bzw. Einführern erfasst werden.
more
The key objective is to celebrate, source, and supply innovations across 12 COVID-19 categories (i.e. response areas). The growing list of 800+ featured innovations includes those that are ready to deploy, plus innovations that could be adapted for COVID-19 responses, or inspire new, much-needed sol...utions. A smaller list is identified as COVID-19 Recognized Innovations for their response efforts so others can more easily find and use them. We are also actively sourcing new innovations designed in response to COVID-19. We hope you find it valuable as we come together to address this global challenge, and would welcome your support so we can continue to help use innovation in tackling future crises yet to come.
more
Solidarity” is an international clinical trial to help find an effective treatment for COVID-19, launched by the World Health Organization and partners.
The Solidarity Trial will compare four treatment options against standard of care, to assess their relative effectiveness against COVID-19. By... enrolling patients in multiple countries, the Solidarity Trial aims to rapidly discover whether any of the drugs slow disease progression or improve survival. Other drugs can be added based on emerging evidence.
Until there is sufficient evidence, WHO cautions against physicians and medical associations recommending or administering these unproven treatments to patients with COVID-19 or people self-medicating with them. WHO is concerned by reports of individuals self-medicating with chloroquine and causing themselves serious harm.
more
A lot of research articles concerning SARS-CoV-2/COVID-19 are published every day. Many of them, so-called pre-prints, are not reviewed in a professional reviewing process at the time of publication. Others are already reviewed and published in well-known journals. Collabovid helps researchers to id...entify the most relevant information by using Natural Language Processing. You can search for any topic you want below. Visit search to review all articles or browse a list of predefined categories. For additional help visit the frequently asked questions.
more
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
Almost all organizations recommend masks for the general public. Unfortunately, earlier in the pandemic, many did exactly the opposite – due to limited data but also due to concerns about diminished mask supply for healthcare workers and out of fear that masked individuals might be tempted to igno...re rules of social distancing. In addition, conflicting national guidelines have led to variable public compliance. A few physicians, in line with some COVidiots, still argue against face masks
more